|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM212997947 |
| 003 |
DE-627 |
| 005 |
20231224020706.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231224s2012 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.clim.2011.10.004
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n0710.xml
|
| 035 |
|
|
|a (DE-627)NLM212997947
|
| 035 |
|
|
|a (NLM)22079331
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Hagan, Robert S
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Targeted immunosuppression
|b no longer naïve
|
| 264 |
|
1 |
|c 2012
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 11.04.2012
|
| 500 |
|
|
|a Date Revised 03.12.2021
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a CommentOn: Clin Immunol. 2012 Feb;142(2):127-38. - PMID 22075384
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 650 |
|
4 |
|a Editorial
|
| 650 |
|
4 |
|a Comment
|
| 650 |
|
7 |
|a mTOR protein, mouse
|2 NLM
|
| 650 |
|
7 |
|a EC 2.7.1.1
|2 NLM
|
| 650 |
|
7 |
|a TOR Serine-Threonine Kinases
|2 NLM
|
| 650 |
|
7 |
|a EC 2.7.11.1
|2 NLM
|
| 700 |
1 |
|
|a Powell, Jonathan D
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 142(2012), 2 vom: 06. Feb., Seite 95-6
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
| 773 |
1 |
8 |
|g volume:142
|g year:2012
|g number:2
|g day:06
|g month:02
|g pages:95-6
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2011.10.004
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 142
|j 2012
|e 2
|b 06
|c 02
|h 95-6
|